UroGen Pharma Ltd URGN
NAS: URGN | ISIN: IL0011407140 14/11/2024
11,86 USD (-2,47%)
(-2,47%)
14/11/2024
Profiel UroGen Pharma Ltd
CEO: Elizabeth Barrett
Werknemers: 206